Heron Therapeutics
HRTX
#8261
Rank
$0.24 B
Marketcap
$1.31
Share price
0.00%
Change (1 day)
-25.14%
Change (1 year)

Earnings for Heron Therapeutics (HRTX)

Earnings in 2025 (TTM): -$13.58 Million USD

According to Heron Therapeutics's latest financial reports the company's current earnings are $0.15 Billion USD. In 2024 the company made an earning of -$13.58 Million USD, an increase over its 2023 earnings that were of -$0.12 Billion USD. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Heron Therapeutics from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$13.58 Million-0.01%
2024 -$13.58 Million-87.72%
2023 -$0.12 Billion-39.26%
2022 -$0.19 Billion-17.52%
2021 -$0.23 Billion-2.9%
2020 -$0.23 Billion11%
2019 -$0.21 Billion14.49%
2018 -$0.18 Billion-9.44%
2017 -$0.2 Billion14.06%
2016 -$0.18 Billion77.42%
2015 -$97.6 Million27.79%
2014 -$76.37 Million38.14%
2013 -$55.29 Million126.29%
2012 -$24.43 Million114.52%
2011 -$11.39 Million14.64%
2010 -$9.94 Million-2.92%
2009 -$10.24 Million-55.6%
2008 -$23.05 Million2.46%
2007 -$22.5 Million19.23%
2006 -$18.87 Million122.61%
2005 -$8.48 Million-9.04%
2004 -$9.32 Million40.92%
2003 -$6.62 Million48.97%
2002 -$4.44 Million-23.18%
2001 -$5.78 Million29.01%
2000 -$4.48 Million-345.99%
1999 $1.82 M-24.15%
1998 $2.4 M-1300%
1997 -$0.2 Million-97.14%
1996 -$7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Alkermes
ALKS
$0.40 B-3,087.26%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Pacira Biosciences
PCRX
$41.82 M-408.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-$0.12 Billion 738.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$66.79 M-591.92%๐Ÿ‡บ๐Ÿ‡ธ USA
SurModics
SRDX
-$11.21 Million-17.46%๐Ÿ‡บ๐Ÿ‡ธ USA